More than a test. Guidance at every step.

Discover the power of the Galleri® Multi-Cancer early detection test. Paired with expert guidance from TELUS Health clinicians, you’ll get more than just results—you’ll get a dedicated support system and a clear, seamless path forward.

$2,000

Call: 1-844-205-7438

What is the Galleri® Multi-Cancer Early Detection test?

The Galleri® test by Grail is the latest in proactive cancer screening. The test screens for a cancer signal across 50+ types of cancer from a single blood draw, giving you and your care team more information to guide what comes next.

Earlier insight, more informed action

The test looks for signals associated with cancer, giving you and your care team additional information to guide next steps.1

Guidance with greater precision

When a cancer signal is detected, the test can indicate where in the body it may be coming from with 93.4% accuracy, helping TELUS Health clinicians coordinate more focused next steps.2

Clarity you can move forward with

A high specificity rate (99.5%) helps minimize false-positive results, allowing next steps to be taken with greater confidence.2

If a positive cancer signal is detected, we take action — together.

Beyond providing advanced blood-based screening, TELUS Health surrounds you with a compassionate clinical team to interpret your results and coordinate any necessary next steps.


Guided next steps

A nurse practitioner reviews your results, answers questions, and arranges appropriate testing.

Diagnostic guidance

Our care team will support you with follow-up testing and will help navigate your care path.

Thoughtful continuity of care

If a cancer signal is detected, we ensure you and your family doctor have the information and support you need.

You can't know everything ahead, but you can choose to know more.

Beyond providing advanced blood-based screening, TELUS Health surrounds you with a compassionate clinical team to interpret your results and coordinate any necessary next steps.

Expanded health visibility

Screens for a shared cancer signal across 50+ cancer types—including many that do not have routine screening guidelines.3

Proactive insights

Gaining additional health insights may offer you valuable context to plan your next steps.4

Designed to complement your care

Integrates smoothly into your current preventive health routine, including Preventive Health Assessments from TELUS Health and healthcare provider-recommended screenings.

Ready to know more?

Connect with our team to learn how the Galleri® Multi-Cancer Early Detection test can complement your personal health routine.

Connect with us

Your experience, step-by-step

How it works

Step 1

Before your appointment:
Complete a brief online questionnaire and consent form, so our clinical team can confirm the test is appropriate for you.

Step 2

During your appointment (15 minutes):
Visit a TELUS Health Care Centre for a quick blood draw. No fasting, pre-test preparation or other procedure is required.

Step 3

After your appointment:
Within two weeks, a TELUS Health clinician will contact you to review your results, explain what they mean and walk you through any next steps.

Proactive screening, with clinical support at every step

Galleri® Multi-Cancer Early Detection

$2,200

  • In clinic blood draw
  • Results review with a clinician

If a cancer signal is detected:

  • Next steps coordinated by a nurse practitioner
  • Support with follow-up testing, where available and clinically appropriate
  • Follow-up clinical evaluation and re-testing protocols, if indicated, managed by your clinician.
Book now

FAQs

Who is this test for?

This test has been tested in people who are 50+ years of age and is intended for individuals without symptoms who want proactive health screening and have an increased risk of cancer. Although a healthcare provider may recommend it for patients under 50 based on specific risk factors, cancer signal detection rates are typically lower for individuals under the age of 50.

What are the cancers that can be detected by this test?

The Galleri® test screens for a signal shared across more than 50 types of cancer:

-Adrenal Cortical Carcinoma
-Ampulla of Vater
-Anus
-Appendix, Carcinoma
-Bile Ducts (Distal, Intrahepatic, Perihilar)
-Bone
-Breast
-Cervix
-Colon and Rectum
-Esophagus and Esophagogastric Junction
-Gallbladder
-Gastrointestinal Stromal Tumor (GIST)
-Gestational Trophoblastic Neoplasms
-Kidney, Bladder, Urinary
-Larynx
-Leukemia
-Liver
-Lung
-Lymphoma (Hodgkin and Non-Hodgkin)
-Melanoma of the Skin
-Merkel Cell Carcinoma
-Mesothelioma, Malignant Pleural
-Nasal Cavity and Paranasal Sinuses
-Nasopharynx
-Neuroendocrine Tumors of the Appendix
-Neuroendocrine Tumors of the Colon and Rectum
-Neuroendocrine Tumors of the Pancreas
-Oral Cavity
-Oropharynx (HPV-Mediated, p16+)
-Oropharynx (p16-) and Hypopharynx
-Ovary, Fallopian Tube and Primary Peritoneum
-Pancreas, exocrine
-Penis, Prostate, Testis
-Plasma Cell Myeloma and Plasma Cell Disorders
-Small Intestine
-Soft Tissue Sarcoma of the Abdomen and Thoracic Visceral Organs
-Soft Tissue Sarcoma of the Head and Neck
-Soft Tissue Sarcoma of the Retroperitoneum
-Soft Tissue Sarcoma of the Trunk and Extremities
-Soft Tissue Sarcoma Unusual Histologies and Sites
-Stomach
-Thyroid
-Ureter, Renal Pelvis
-Uterus, Carcinoma and Carcinosarcoma
-Uterus, Sarcoma
-Vagina, Vulva

How long does it take before I get my results?

You will receive your results within 2 weeks. A clinician will call you to provide details about your results.

Is this a diagnostic test?

No, the Galleri® test is strictly a screening test that indicates when further diagnostic workup is needed. A "Cancer Signal Detected" result requires confirmatory diagnostic evaluation by medically established procedures (e.g., imaging) to confirm cancer

TELUS Health will help you navigate your next steps to get a diagnosis if a cancer signal is detected, including coordinating targeted imaging, oncology referral and a direct handover into the public system.

Does this replace my standard provincial cancer screenings?

No, the test should be used in addition to healthcare provider recommended screenings. It is not a replacement for standard, publicly available provincial cancer screenings such as mammograms, colonoscopies or Pap smears/HPV testing.

What happens if a cancer signal is detected?

Your nurse practitioner will guide you through your options, which may include public or private diagnostic imaging when available and indicated. The cost of this initial diagnostic imaging will be covered by TELUS Health where private imaging is available and indicated.

Are my results going to be shared with my insurance company?

No, we take data privacy and security very seriously. Your results are for your eyes only and will be handled in keeping with our Privacy Commitments.

Is the Galleri® Multi-Cancer Early Detection test covered by my insurance plan?

The test is not covered under public or government health insurance plans in Canada.
However, the cost may be reimbursable through your private health insurance or benefits provider. You should review the terms of your private health insurance plan or consult with your insurance plan provider to determine if this is eligible for reimbursement under your private health insurance plan or any other supplemental benefits such as a Health Spending Account (HSA).

How is the Galleri® test regulated, and where is it processed?

The Galleri® test is classified as an unapproved laboratory-developed test (LDT). Your blood sample is sent directly to GRAIL’s CLIA-certified and CAP-accredited laboratory in the United States for advanced genomic processing. Because it is a private screening tool rather than a diagnostic medical device, it is not licensed or approved by Health Canada or the FDA.

Terms and conditions

Galleri® Multi-Cancer

Early Detection Test Information:
The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older. The Galleri test is a screening tool designed to detect cancer signals and predict the tissue of origin; it is NOT a diagnostic test and a positive result is NOT a cancer diagnosis. The test does not detect all cancers and must be used as a supplement to, and NOT a replacement for, routine provincial guideline-recommended cancer screenings (e.g., mammograms, colonoscopies, Pap tests). The Galleri test does not predict future cancer risk. Requisition required, provided by TELUS Health clinicians.

Contraindications:
The Galleri® test is not recommended for individuals who are pregnant, 21 years of age or younger, or currently undergoing active cancer treatment.

Interpreting Results:
Test results must be evaluated by a licensed healthcare provider in the context of complete medical history and clinical findings. A "No Cancer Signal Detected" result does not rule out the presence of cancer. A "Cancer Signal Detected" result requires confirmatory diagnostic evaluation (such as imaging or biopsy) by medically established procedures. False positive (a cancer signal detected when cancer is not present) and false negative (a cancer signal not detected when cancer is present) results do occur.

Laboratory Accreditation & Regulatory Status:
The Galleri® test is developed, manufactured, and processed by GRAIL, Inc. at its clinical laboratory in the United States, which is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists (CAP). The Galleri® test has not been cleared, approved, or licensed by Health Canada or the U.S. Food and Drug Administration (FDA).

TELUS Health Care Centres (THCC) Program & Care Boundaries:
• Private Uninsured Service: The Galleri® test is a private-pay service and is not covered under provincial health insurance plans (e.g., OHIP, MSP, RAMQ).
• Scope of Care: THCC provides pre-test screening, blood collection, result delivery, and initial diagnostic navigation. THCC is not a cancer diagnostic center or oncology practice and does not provide ongoing cancer treatment, surgeries, or long-term management.
• Follow-Up Imaging Coverage: Where private options are available in the patient's province, THCC covers the cost of one (1) initial targeted diagnostic imaging scan directly requisitioned by a THCC clinician following a "Cancer Signal Detected" result. THCC is not responsible for the costs of non-requisitioned tests, secondary imaging, private specialist consultations, biopsies, or ongoing treatments.
• Independent Imaging Providers: All follow-up diagnostic imaging is performed by independent third-party imaging facilities. THCC does not own or operate these facilities and is not liable for their clinical procedures or equipment.
• Cross-Border Data Transfer: Biological samples and personal health information are transferred to GRAIL's accredited laboratory in the United States and are subject to the applicable laws and governmental access rights of that jurisdiction.

Sources:
1 - https://www.ontario.ca/page/cancer-prevention-and-care / https://www.quebec.ca/en/health/advice-and-prevention/screening-and-carrier-testing-offer / https://www.bccancer.bc.ca/screening / https://www.albertahealthservices.ca/cancer/Page18297.aspx
2- Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Database: Incidence - SEER 18 Regs Research Data, Nov 2018 Sub. Includes persons aged 50-79 diagnosed 2006-2015. [GRAIL, Inc. Data on file: GA-2021-0004]
3 - GRAIL, Inc. Enhanced Cancer Signal Origin prediction. [Data on file: VV-TMF-59592].
4 - Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Database: Incidence - SEER 18 Regs Research Data, Nov 2018 Sub. Includes persons aged 50-79 diagnosed 2006-2015. [GRAIL, Inc. Data on file: GA-2021-0004]
5 - Canadian Cancer Statistics Dashboard. https://cancerstats.ca. (accessed [2026, August 19]).
6 - https://cancer.ca/en/research/cancer-statistics#:~:text=2%20in%205%20Canadians%20are,Cancer%20statistics



© TELUS Health

Your privacy is important to us. We'll use your information only to schedule your consultation and share relevant health resources. View our Privacy Policy.